Maria Rita Migliorino

Author PubWeight™ 9.49^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.	J Natl Cancer Inst	2003	3.41
2	Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.	J Clin Oncol	2005	2.11
3	Supportive care in patients with advanced non-small-cell lung cancer.	Br J Cancer	2003	1.04
4	Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trial.	J Thorac Oncol	2007	0.93
5	Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven Stage IIIA(N2) nonsmall cell lung carcinoma: a Phase II multicenter study.	Cancer	2003	0.79
6	Phase I/II trial of gemcitabine plus cisplatin and etoposide in patients with small-cell lung cancer.	Lung Cancer	2003	0.77
7	Phase II study of gemcitabine-cisplatin-paclitaxel triplet as induction chemotherapy in inoperable, locally-advanced non-small cell lung cancer.	Lung Cancer	2003	0.77
8	Induction therapy with paclitaxel and carboplatin followed by hyperfractionated radiotherapy plus weekly concurrent chemotherapy and subsequent consolidation therapy in unresectable locally advanced non-small-cell lung cancer.	Tumori	2007	0.77
9	Neoadjuvant strategies for non-small cell lung cancer.	Suppl Tumori	2004	0.75
10	Docetaxel administered every two weeks as second-line chemotherapy for advanced non-small cell lung cancer: a phase II study.	Anticancer Res	2005	0.75
11	Role of induction chemotherapy in resectable N2 non-small cell lung cancer.	J Thorac Oncol	2007	0.75